Browse studies
Find your next paid study
2 recruiting studies matching your filters
Phase 2
A Phase II Study With a Safety Run-In of the Addition of N-803, a Novel IL-15 Super-Agonist, to a Chemoimmunotherapy Backbone for the Treatment of Patients With Relapsed or Refractory Neuroblastoma
The study participant is being asked to take part in this research study because the participant has been diagnosed with neuroblastoma that did not fully respo…
Neuroblastoma Recurrent
St. Jude Children's Research HospitalNCT07085338
Phase 1
Feasibility Study of Prolonged Administration of Naxitamab, Irinotecan, and Temozolomide for Patients With Relapsed or Refractory Neuroblastoma
This research is being done to investigate a treatment regimen of Irinotecan, Temozolomide, and Sargramostin, and an immunotherapy called Naxitamab and whether…
NeuroblastomaNeuroblastoma RecurrentRelapsed Neuroblastoma+1 more
Steven DuBois, MDNCT07027748